Seminal reservoirs during an HIV type 1 eradication trial

AIDS Research and Human Retroviruses

Volumn 21, Issue 9, 2005, Pages 768-775

  Nunnari, Giuseppe ^a   Leto, Daniela ^a   Sullivan, Julie ^a   Xu, Yan ^a   Mehlman, Ketti E ^a   Kulkosky, Joseph ^a   Pomerantz, Roger J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; HYDROXYUREA; OKT 3; RECOMBINANT INTERLEUKIN 2; VIRUS DNA; VIRUS RNA;

ARTICLE; CASE REPORT; ERADICATION THERAPY; EVOLUTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOW DRUG DOSE; MACROPHAGE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROVIRUS; SEMINAL PLASMA; VIRION; VIRUS LOAD;

AMINO ACID SEQUENCE; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DIDANOSINE; DNA, VIRAL; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; HYDROXYUREA; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; MALE; MOLECULAR SEQUENCE DATA; MUROMONAB-CD3; NUCLEIC ACID SYNTHESIS INHIBITORS; PEPTIDE FRAGMENTS; PHYLOGENY; PROVIRUSES; RNA, VIRAL; SEMEN; SEQUENCE ALIGNMENT; TREATMENT OUTCOME; VIREMIA; WITHHOLDING TREATMENT;

EID: 26444506310     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2005.21.768     Document Type: Article

References (15)

1. Palella FJ, Delaney KM, Moorman AC, et al.: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-860.
2. Hammer SM, Squires KE, Hughes MD, et al.: A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team. N Engl J Med 1997;337:725-733.
3. Gupta P, Mellors J, Kingsley L, et al.: High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and non-nucleoside reverse transcriptase inhibitors. J Virol 1997;71: 6271-6275.
4. Chun TW, Carruth L, Finzi D, et al.: Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature. 1997;387:183-188.
5. Domadula G, Zhang H, VanUitert B, et al.: Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy. J Am Med Assoc 1999;282:1627-1632.
6. Finzi D, Hermankova M, Pierson T, et al.: Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997;278:1295-1300.
7. Zhang H, Dornadula G, Beumont M, et al.: Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N Engl J Med 1998;339:1803-1809.
8. Pomerantz RJ: Residual HIV-1 infection during antiretroviral therapy: The challenge of viral persistence. AIDS 2001;15:1201-1211.
9. Sonza S, Mutimer HP, Oelrichs R, et al.: Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy. AIDS 2001;15:17-22.
10. Kulkosky J, Nunnari G, Otero M, et al.: Intensification and stimulation therapy for human immunodeficiency virus type 1 reservoirs in infected persons receiving virally suppressive highly active antiretroviral therapy. J Infect Dis 2002;186:1403-1411.
11. Lori F, Malykh A, Cara A, et al.: Hydroxyurea as an inhibitor of human immunodeficiency virus type 1 replication. Science 1994;266:801-804.
12. Zhang L, Chung C, Hu B-S, et al.: Genetic characterization of rebounding of HIV-1 after cessation of highly active antiretroviral therapy. J Clin Invest 2000;106:839-845.
13. Chun T-W, Davey RT, Ostrowski M, et al.: Relationship between pre-existing viral reservoirs and the re-emergency of plasma viremia after discontinuation of highly active antiretroviral therapy. Nat Med 2000;6:757-761.
14. Nunnari G, Otero M, Dornadula G, et al.: Residual HIV-1 disease in seminal cells of HIV-1-infected men on suppressive HAART: Latency without on-going cellular infections. AIDS 2002;16: 39-45.
15. Kulkosky J, Sullivan J, Xu Y, et al.: Genotypic alteration of HAART-persistent HIV-1 reservoirs in vivo. Virology 2003;314: 617-629.